Business & regional news

Month Year

Month Year

Apr 30, 2024

CRISTAL study published in The Lancet Diabetes & Endocrinology shows promising outcomes for pregnant women living with type 1 diabetes

Study shows the investigational use of the MiniMed™ 780G system improved glycemic control during pregnancy. Medtronic, a global leader in healthcare technology, today announced the results of...
- Diabetes
Apr 29, 2024

April 29 proclaimed ‘Medtronic Day’ in Minnesota

Honorary day celebrates Medtronic roots, 75th anniversary year
- Photos 6
Apr 24, 2024

New randomized controlled data from VenaSeal Spectrum Program reinforces evidence that VenaSeal™ closure system is safe and effective
- Peripheral Vascular Health
Apr 23, 2024

Medtronic welcomes compelling evidence from Europe and Asia that reveal advanced hybrid closed loop systems are more cost-effective than standard management of type 1 diabetes

Groundbreaking studies in Europe and Singapore demonstrate the Medtronic MiniMed™ 780G system can generate cost-savings for health systems. Medtronic, a global leader in healthcare technology,...
- Diabetes
Apr 22, 2024

Medtronic launches the Avalus Ultra™ valve engineered for ease of use at implant and lifetime patient management

Next-generation Avalus Ultra valve is Medtronic’s most advanced surgical aortic tissue valve built on 10 years of clinical experience with the Avalus™ valve
- Cardiac Surgery
Apr 18, 2024

Medtronic sets new standard with Live Stream technology and new AI analysis for laparoscopic and robotic-assisted procedures
- Surgical
- Photos 2
Mar 27, 2024

Medtronic receives top accolade in 3 countries at Healthcare Asia Medtech Awards 2024
- Asia Pacific
Mar 19, 2024

Medtronic and Exact Sciences co-sponsor San Jose Sharks game, raising awareness of colorectal cancer screening

Patient advocate and youth entrepreneur Grace Bowyer will join company executives, shining light on the critical importance for colon cancer screening
- Gastrointestinal
Mar 19, 2024

Medtronic receives Health Canada licence for the Symplicity Spyral™ multi-electrode renal denervation catheter and Symplicity G3™ RF generator

Medtronic today announced it received a license from Health Canada for its Symplicity Spyral™ multi-electrode Renal Denervation (RDN) System. This is indicated for the management of essential...
- Cardiovascular Diagnostics and Services
- Coronary and Renal Denervation
Mar 11, 2024

New late-breaking data from Medtronic Evolut™ Low Risk Trial demonstrate strong clinical and cost-effectiveness benefits of TAVR platform

CRT 2024: Evolut TAVR is a safe, effective, and economically cost-effective treatment option for low-risk severe aortic stenosis patients compared to surgery up to four years
- Structural Heart and Aortic

Show per page